An Evaluation of the Effectiveness of Darbepoetin alfa 300 mcg Every 3 Weeks (Q3W) on Clinical Outcomesin Cancer Patients with Chemotherapy-Induced Anemia.Ralph V. Boccia, G. A. Otterson, Dianne Tomita et al.|Blood|2004Cited by 2
Effectiveness of Darbepoetin alfa Administered Every 3 Weeks on Clinical Outcomes in Patients with Hematologic Malignancies and Chemotherapy-Induced Anemia.Ralph V. Boccia, G. A. Otterson, Peter T. Silberstein et al.|Blood|2005Cited by 1